Ben Ayres
👤 PersonAppearances Over Time
Podcast Appearances
to a full multidisciplinary team that should include lymphedema experts, psychological counsellors, psychosexual counsellors to really help. And it may be that your hospital is a smaller hospital and can't provide that. Well then it's really important we start working as networks, start working together in a more networked fashion so that those services can be provided to patients.
to a full multidisciplinary team that should include lymphedema experts, psychological counsellors, psychosexual counsellors to really help. And it may be that your hospital is a smaller hospital and can't provide that. Well then it's really important we start working as networks, start working together in a more networked fashion so that those services can be provided to patients.
to a full multidisciplinary team that should include lymphedema experts, psychological counsellors, psychosexual counsellors to really help. And it may be that your hospital is a smaller hospital and can't provide that. Well then it's really important we start working as networks, start working together in a more networked fashion so that those services can be provided to patients.
Talking about this multidisciplinary approach to care, I don't know, Rick, if you've got anything you want to add about the importance of multidisciplinary care in the treatment that you had for your bladder cancer and clearly how we should be trying to work as teams to support our patients rather than as individuals.
Talking about this multidisciplinary approach to care, I don't know, Rick, if you've got anything you want to add about the importance of multidisciplinary care in the treatment that you had for your bladder cancer and clearly how we should be trying to work as teams to support our patients rather than as individuals.
Talking about this multidisciplinary approach to care, I don't know, Rick, if you've got anything you want to add about the importance of multidisciplinary care in the treatment that you had for your bladder cancer and clearly how we should be trying to work as teams to support our patients rather than as individuals.
Lovely. Thank you very much, Rick, on that. And Rob, thank you for joining us as well this evening. Thank you both for a very, very thoughtful and thorough discussion on how we might approach lack of awareness, isolation, patient advocacy, and how we might try and make a difference for these patients.
Lovely. Thank you very much, Rick, on that. And Rob, thank you for joining us as well this evening. Thank you both for a very, very thoughtful and thorough discussion on how we might approach lack of awareness, isolation, patient advocacy, and how we might try and make a difference for these patients.
Lovely. Thank you very much, Rick, on that. And Rob, thank you for joining us as well this evening. Thank you both for a very, very thoughtful and thorough discussion on how we might approach lack of awareness, isolation, patient advocacy, and how we might try and make a difference for these patients.
I'd also like to again thank Backtable for their support in recording and producing this podcast and the Global Society of Rare Genitourinary Tumors for this opportunity to talk about this topic. If there are any clinicians or patients out there with rare genitourinary cancers that would like to find out more, then the Global Society of Rare Genitourinary Tumors is a good place to start.
I'd also like to again thank Backtable for their support in recording and producing this podcast and the Global Society of Rare Genitourinary Tumors for this opportunity to talk about this topic. If there are any clinicians or patients out there with rare genitourinary cancers that would like to find out more, then the Global Society of Rare Genitourinary Tumors is a good place to start.
I'd also like to again thank Backtable for their support in recording and producing this podcast and the Global Society of Rare Genitourinary Tumors for this opportunity to talk about this topic. If there are any clinicians or patients out there with rare genitourinary cancers that would like to find out more, then the Global Society of Rare Genitourinary Tumors is a good place to start.
Thank you again for your time, gentlemen. Thank you, Ben. Thank you.
Thank you again for your time, gentlemen. Thank you, Ben. Thank you.
Thank you again for your time, gentlemen. Thank you, Ben. Thank you.